FGFR2 and intrahepatic cholangiocarcinoma: Given the large sample size (728 in our study vs. 40–257 for ICC in15, 16, 17, 29, 30), our epidemiology study may offer a more reliable estimate of FGFR2 rearrangement frequency in Chinese patients with ICC.